Journal
JOURNAL OF MEDICAL MICROBIOLOGY
Volume 60, Issue 3, Pages 381-383Publisher
MICROBIOLOGY SOC
DOI: 10.1099/jmm.0.027235-0
Keywords
-
Categories
Ask authors/readers for more resources
Daptomycin is licensed for the management of Staphylococcus aureus infections in adults, including those caused by meticillin-resistant S. aureus (MRSA). Few data exist on paediatric use or dose guidance in neonates. We report the case of a neonate with MRSA bacteraemia successfully managed with daptomycin. Dose requirements were substantially higher than those recommended for adults.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
